Loading…
Reported covered position: Policy Fellow, Rep. Edolphus Towns, Aug06 - Feb07; Prof Staff Mber, Commit on Eng and Com, Feb 07 - Jan 11; Health Policy Advisor, Rep. John D. Dingell, Jan 09 - Jan 11; CoS, Rep. Cedric Richmond, Jan 11 - Mar 19.
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Mikaela Naylon Give Kids a Chance Act
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to Rare Pediatric Disease Priority Review Voucher Program reauthorization; Issues related to H.R. 1262 / S. 3302 - Mikaela Naylon Give Kids a Chance Act of 2025; Issues related to the Consolidated Appropriations Act, 2026 (P.L. 119-75), including the extension of authority to issue priority review vouchers to encourage treatments for rare pediatric diseases; Issues related to the biotech ecosystem, including most-favored-nation drug pricing; Issues related to PBM reform, PAHPA reauthorization; and PDUFA reauthorization.
Mikaela Naylon Give Kids a Chance Act
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: AKIN GUMP STRAUSS HAUER & FELD
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
OPENAI OPCO, LLC via AKIN GUMP STRAUSS HAUER & FELD
2026 · third_quarter · Q3
Issues related to artificial intelligence legislation and regulation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTHCARE DISTRIBUTION ALLIANCE via AKIN GUMP STRAUSS HAUER & FELD
2026 · third_quarter · RR
Source: Senate LDA
| COALITION FOR 21ST CENTURY PATENT REFORM |
| 18 |
| 2020–2025 |
| DOORDASH | 18 | 2020–2024 |
| BOOZ ALLEN HAMILTON INC. | 17 | 2022–2026 |
| EMVCO, LLC | 17 | 2020–2026 |
| CENTER FOR SPORTFISHING POLICY | 16 | 2021–2024 |
| INTUIT, INC. AND AFFILIATES (FORMERLY INTUIT, INC.) | 16 | 2021–2024 |
| STANLEY BLACK & DECKER INC | 16 | 2021–2025 |
| MCKESSON CORPORATION | 15 | 2019–2022 |
| BIOTECHNOLOGY INNOVATION ORGANIZATION | 14 | 2023–2026 |
| CVS HEALTH | 14 | 2019–2023 |
| EXXON MOBIL CORP | 14 | 2019–2023 |
| FINANCIAL SERVICES FORUM | 14 | 2019–2023 |
| US PHYSICIAN PARTNERS (INFORMAL COALITION) | 14 | 2019–2022 |
| ACCENTURE LLP | 13 | 2019–2023 |
| EDUCATION REFORM NOW ADVOCACY | 13 | 2021–2026 |
| KOHLBERG KRAVIS ROBERTS & COMPANY | 13 | 2022–2026 |
| NATIONAL INDEPENDENT VENUE ASSOCIATION | 13 | 2020–2026 |
| HP INC | 12 | 2021–2023 |
| PATHWARD, NATIONAL ASSOCIATION (FKA PATHWARD (FORMERLY METABANK, N.A.)) | 12 | 2020–2024 |
| SHATTERPROOF | 12 | 2023–2026 |
| SAP AMERICA INC. | 11 | 2021–2026 |
| AMERILIFE GROUP, LLC | 10 | 2024–2026 |
| HEALTHCARE LEADERSHIP COUNCIL | 10 | 2019–2021 |
| SIEMENS HEALTHINEERS (FKA VARIAN MEDICAL SYSTEMS, INC.) | 10 | 2019–2022 |
| COALITION OF SEMICONDUCTOR EQUIPMENT MANUFACTURERS | 9 | 2021–2026 |
| MOBILITY CAPITAL FINANCE, INC. DBA MOCAFI | 9 | 2020–2021 |
| AMERICAN LIBRARY ASSOCIATION | 8 | 2021–2023 |
| ANHEUSER-BUSCH COMPANIES, INC. | 8 | 2022–2026 |
| CHARTER COMMUNICATIONS, INC. | 8 | 2019–2020 |
| THE UNITED STATES FUND FOR UNICEF | 8 | 2023–2024 |
| KIPP FOUNDATION | 7 | 2024–2026 |
| OPENAI OPCO, LLC | 7 | 2024–2026 |
| ABBOTT LABORATORIES | 6 | 2020–2022 |
| AMERICAN AIRLINES, INC. | 6 | 2021–2026 |
| BRADLEY LANE INVESTMENT COMPANY | 6 | 2022–2023 |
| ResMed Corp. | 6 | 2019–2020 |
| VANTIVE US HEALTHCARE LLC | 6 | 2025–2026 |
| ADOBE, INC. | 5 | 2023–2024 |
| ARGENTEM CREEK PARTNERS LP | 5 | 2022–2024 |
| ATALCO GRAMERCY LLC (ATLANTIC ALUMINA) | 5 | 2023 |
| CADENCE DESIGN SYSTEMS INC | 5 | 2023–2024 |
| FAIR ISAAC CORPORATION (FICO) | 5 | 2024–2026 |
| MOTION PICTURE ASSOCIATION OF AMERICA | 5 | 2019–2020 |
| NATIONAL ASSOCIATION OF THEATRE OWNERS | 5 | 2020 |
| TEXAS ASSOCIATION FOR HOME CARE & HOSPICE | 5 | 2019–2020 |
| VERIZON COMMUNICATIONS | 5 | 2022–2024 |
| BLACKROCK FUNDS SERVICES GROUP LLC | 4 | 2023–2024 |
| LYFT INC. | 4 | 2020 |
| MICROSOFT CORPORATION | 4 | 2025 |
| MSC Mediterranean Shipping Company SA | 4 | 2021 |
| NIPPON STEEL CORPORATION | 4 | 2023–2024 |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 4 | 2019–2021 |
| ALLIANCE FOR AGING RESEARCH | 3 | 2024 |
| CONSUMER SAFETY TECHNOLOGY, LLC DBA INTOXALOCK | 3 | 2019–2020 |
| DOMA HOLDINGS, INC | 3 | 2023 |
| FIX THE TIX COALITION | 3 | 2023–2025 |
| GCI HOLDINGS LLC | 3 | 2023 |
| INTERNATIONAL BUSINESS MACHINES CORPORATION | 3 | 2021 |
| L'OREAL USA | 3 | 2024 |
| PROFESSIONAL BACKGROUND SCREENERS ASSOCIATION | 3 | 2019 |
| TERADYNE, INC. | 3 | 2023 |
| THE LEADERSHIP CONFERENCE ON CIVIL AND HUMAN RIGHTS | 3 | 2024–2025 |
| VEON LTD. | 3 | 2024 |
| 1-800 CONTACTS | 2 | 2025–2026 |
| 1HUDDLE INC | 2 | 2020 |
| ALKEUS PHARMACEUTICALS, INC. | 2 | 2024 |
| AMAZON CORPORATE LLC | 2 | 2019 |
| AMERICAN MEDICAL REHABILITATION PROVIDERS ASSOCIATION | 2 | 2020 |
| AMGEN USA, INC. | 2 | 2020–2024 |
| CUMBERLAND COMMUNITY IMPROVEMENT DISTRICT | 2 | 2019–2023 |
| ENPOWER INC. | 2 | 2022 |
| FLETCHER GROUP INC. | 2 | 2022–2024 |
| FORTESCUE FUTURE INDUSTRIES PTY, LTD. | 2 | 2023–2024 |
| Firekeepers Development Authority | 2 | 2020–2021 |
| GILEAD SCIENCES, INC. | 2 | 2022 |
| KEIDANREN | 2 | 2023 |
| LION ELASTOMERS LLC | 2 | 2022 |
| MIDDLEGROUND CAPITAL | 2 | 2020 |
| NATIONAL FIRE PROTECTION ASSOCIATION | 2 | 2023–2024 |
| NEXTWAVE HOLDCO, LLC | 2 | 2024 |
| PEOPLE CENTER, INC. | 2 | 2023 |
| PROPONENTS OF AFFORDABLE HOUSING, INC. | 2 | 2020 |
| SOCIETY OF MANUFACTURING ENGINEERS | 2 | 2024–2025 |
| TESLA INC. | 2 | 2024 |
| TEXAS SOUTHERN UNIVERSITY | 2 | 2021 |
| TransAtlantic Petroleum Ltd. | 2 | 2019 |
| ALLIANCE OF AUTOMOBILE MANUFACTURERS | 1 | 2019 |
| ALTICE USA INC. | 1 | 2020 |
| AMERICAN BUS ASSOCIATION, INC. | 1 | 2023 |
| AMERICAN COALITION OF INDEPENDENT CONTENT PRODUCTION | 1 | 2021 |
| AMERICAN COUNCIL OF LIFE INSURERS | 1 | 2023 |
| ASURION LLC | 1 | 2023 |
| AXON ENTERPRISE, INC. | 1 | 2025 |
| BAIN CAPITAL, LLC | 1 | 2024 |
Issues related to Rare Pediatric Disease Priority Review Voucher Program reauthorization; Issues related to H.R. 1262/S. 3302 - Mikaela Naylon Give Kids a Chance Act of 2025; Issues related to the Consolidated Appropriations Act, 2026 (P.L. 119-75), including the extension of authority to issue priority review vouchers to encourage treatments for rare pediatric diseases.
Grown in America Act of 2025
Client: ANHEUSER-BUSCH COMPANIES, INC. · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to H.R. 1707 - Grown in America Act of 2025.
Issues related to Substance Use Disorder programs; SUPPORT for Patients and Communities Reauthorization Act of 2025 (P.L. 119-44); Issues related to H.R. 5281/S. 3750 - REAL Health Providers Act; Issues related to H.R. 2509/S. 931 - COMPLETE Care Act; Issues related to behavioral health; Issues related to the Substance Abuse and Mental Health Services Administration's mental health and addiction treatment locator, FindTreatment.gov, and including quality indicators for addiction treatment.
Issues related to Substance Use Disorder programs; Issues related to SUPPORT for Patients and Communities Reauthorization Act of 2025 (P.L. 119-44) funding; Issues related to H.R. 2509/S. 931 - COMPLETE Care Act; Issues related to behavioral health; Issues related to the Substance Abuse and Mental Health Services Administration's mental health and addiction treatment locator, FindTreatment.gov, and including quality indicators for addiction treatment.
Issues related to student athletes and college athletics, including H.R. 4312 - SCORE Act, and S.____ - College Sports Competitive Act.
Issues related to student athletes and college athletics, including H.R. 4312 - SCORE Act, and S.____ - College Sports Competitive Act.
Issues related to Substance Use Disorder programs; SUPPORT for Patients and Communities Reauthorization Act of 2025 (P.L. 119-44); Issues related to H.R. 5281/S. 3750 - REAL Health Providers Act; Issues related to H.R. 2509/S. 931 - COMPLETE Care Act; Issues related to behavioral health; Issues related to the Substance Abuse and Mental Health Services Administration's mental health and addiction treatment locator, FindTreatment.gov, and including quality indicators for addiction treatment.
Mikaela Naylon Give Kids a Chance Act of 2025
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to Rare Pediatric Disease Priority Review Voucher Program reauthorization; Issues related to H.R. 1262/S. 3302 - Mikaela Naylon Give Kids a Chance Act of 2025; Issues related to the Consolidated Appropriations Act, 2026 (P.L. 119-75), including the extension of authority to issue priority review vouchers to encourage treatments for rare pediatric diseases.
Mikaela Naylon Give Kids a Chance Act of 2025
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to Rare Pediatric Disease Priority Review Voucher Program reauthorization; Issues related to H.R. 1262 / S. 3302 - Mikaela Naylon Give Kids a Chance Act of 2025; Issues related to the Consolidated Appropriations Act, 2026 (P.L. 119-75), including the extension of authority to issue priority review vouchers to encourage treatments for rare pediatric diseases; Issues related to the biotech ecosystem, including most-favored-nation drug pricing; Issues related to PBM reform, PAHPA reauthorization; and PDUFA reauthorization.
Issues related to Substance Use Disorder programs; SUPPORT for Patients and Communities Reauthorization Act of 2025 (P.L. 119-44); Issues related to H.R. 5281/S. 3750 - REAL Health Providers Act; Issues related to H.R. 2509/S. 931 - COMPLETE Care Act; Issues related to behavioral health; Issues related to the Substance Abuse and Mental Health Services Administration's mental health and addiction treatment locator, FindTreatment.gov, and including quality indicators for addiction treatment.
Issues related to Substance Use Disorder programs; SUPPORT for Patients and Communities Reauthorization Act of 2025 (P.L. 119-44); Issues related to H.R. 5281/S. 3750 - REAL Health Providers Act; Issues related to H.R. 2509/S. 931 - COMPLETE Care Act; Issues related to behavioral health; Issues related to the Substance Abuse and Mental Health Services Administration's mental health and addiction treatment locator, FindTreatment.gov, and including quality indicators for addiction treatment.
Issues related to Substance Use Disorder programs; Issues related to SUPPORT for Patients and Communities Reauthorization Act of 2025 (P.L. 119-44) funding; Issues related to H.R. 2509/S. 931 - COMPLETE Care Act; Issues related to behavioral health; Issues related to the Substance Abuse and Mental Health Services Administration's mental health and addiction treatment locator, FindTreatment.gov, and including quality indicators for addiction treatment.
Mikaela Naylon Give Kids a Chance Act
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to Rare Pediatric Disease Priority Review Voucher Program reauthorization; Issues related to H.R. 1262/S. 932 - Give Kids a Chance Act of 2025.
Mikaela Naylon Give Kids a Chance Act
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to Rare Pediatric Disease Priority Review Voucher Program reauthorization; H.R. 1262/S. 932 - Give Kids a Chance Act of 2025.
Mikaela Naylon Give Kids a Chance Act
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to PAHPA reauthorization; Rare Pediatric Disease Priority Review Voucher Program reauthorization (H.R. 1262/S. 932 - Give Kids a Chance Act of 2025).
Mikaela Naylon Give Kids a Chance Act
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to Rare Pediatric Disease Priority Review Voucher Program reauthorization; Issues related to H.R. 1262/S. 932 - Give Kids a Chance Act of 2025; Issues related to biotechnology innovation ecosystems.
Collision Avoidance Systems Act of 2025
Client: WILLIAMS & LAKE, LLC · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to pulsating brake light safety including H.R. 1361 - Collision Avoidance Systems Act of 2025.
TICKET Act
Client: NATIONAL INDEPENDENT VENUE ASSOCIATION · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to predatory and deceptive ticketing practices, including H.R. 1402/S. 281 - TICKET Act; S. 196 - MAIN Event Ticketing Act.
TICKET Act
Client: NATIONAL INDEPENDENT VENUE ASSOCIATION · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to predatory and deceptive practices in the ticketing market, including H.R. 1402/S. 281 - TICKET Act, and H.R. 2713/S. 196 - MAIN Event Ticketing Act.
Issues related to predatory and deceptive practices in the ticketing market, including H.R. 1402/S. 281 - TICKET Act; S. 196 - MAIN Event Ticketing Act.
Grown in America Act of 2025
Client: ANHEUSER-BUSCH COMPANIES, INC. · Firm: AKIN GUMP STRAUSS HAUER & FELD
H.R. 1707 - Grown in America Act of 2025; Issues related to tax incentives in support grown in America products.
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: SHATTERPROOF · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to Substance Use Disorder programs; H.R. 2483 - SUPPORT for Patients and Communities Reauthorization Act of 2025; Issues related to behavioral health; Promoting enhancements to the Substance Abuse and Mental Health Services Administration's mental health and addiction treatment locator, FindTreatment.gov, to include quality indicators for addiction treatment.
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: SHATTERPROOF · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to Substance Use Disorder programs; H.R. 2483/S. 2121 - SUPPORT for Patients and Communities Reauthorization Act of 2025; Issues related to H.R. 5281 - REAL Health Providers Act; Issues related to behavioral health; Issues related to the Substance Abuse and Mental Health Services Administration's mental health and addiction treatment locator, FindTreatment.gov, and including quality indicators for addiction treatment.
MAIN Event Ticketing Act
Client: NATIONAL INDEPENDENT VENUE ASSOCIATION · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to predatory and deceptive practices in the ticketing market, including H.R. 1402/S. 281 - TICKET Act, and H.R. 2713/S. 196 - MAIN Event Ticketing Act.
Better CARE for Animals Act of 2025
Client: HUMANE WORLD ACTION FUND (FKA HUMANE SOCIETY LEGISLATIVE FUND) · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to animal welfare, including H.R. 3732 - BARK Act, H.R. 3112/S. 1538 Better CARE for Animals Act of 2025, and Fiscal Year 2026 appropriations language regarding wild horses and burros; Issues related to S. 1326 - Food Security and Farm Protection Act.
Patent Eligibility Restoration Act of 2025
Client: COALITION FOR 21ST CENTURY PATENT REFORM · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to patent reform legislation; Issues related to H.R. 3152/S.1546 - Patent Eligibility Restoration Act of 2025; Issues related to H.R. 3160/S. 1553 - PREVAIL Act.
PREVAIL Act
Client: COALITION FOR 21ST CENTURY PATENT REFORM · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to patent reform legislation; Issues related to H.R. 3152/S.1546 - Patent Eligibility Restoration Act of 2025; Issues related to H.R. 3160/S. 1553 - PREVAIL Act.
BARK Act of 2025
Client: HUMANE WORLD ACTION FUND (FKA HUMANE SOCIETY LEGISLATIVE FUND) · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to animal welfare, including H.R. 3732 - BARK Act, H.R. 3112/S. 1538 Better CARE for Animals Act of 2025, and Fiscal Year 2026 appropriations language regarding wild horses and burros; Issues related to S. 1326 - Food Security and Farm Protection Act.
Issues related to student athletes and college athletics; Issues related to H.R. 4312 - SCORE Act.
Issues related to student athletes and college athletics; Issues related to H.R. 4312 - SCORE Act.
Issues related to Substance Use Disorder programs; H.R. 2483/S. 2121 - SUPPORT for Patients and Communities Reauthorization Act of 2025; Issues related to H.R. 5281 - REAL Health Providers Act; Issues related to behavioral health; Issues related to the Substance Abuse and Mental Health Services Administration's mental health and addiction treatment locator, FindTreatment.gov, and including quality indicators for addiction treatment.
Issues related to Substance Use Disorder programs; SUPPORT for Patients and Communities Reauthorization Act of 2025 (P.L. 119-44); Issues related to H.R. 5281 - REAL Health Providers Act; Issues related to behavioral health; Issues related to the Substance Abuse and Mental Health Services Administration's mental health and addiction treatment locator, FindTreatment.gov, and including quality indicators for addiction treatment; Issues related to regulating intoxicating hemp products.
Food Security and Farm Protection Act
Client: HUMANE WORLD ACTION FUND (FKA HUMANE SOCIETY LEGISLATIVE FUND) · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to animal welfare, including H.R. 3732 - BARK Act, H.R. 3112/S. 1538 Better CARE for Animals Act of 2025, and Fiscal Year 2026 appropriations language regarding wild horses and burros; Issues related to S. 1326 - Food Security and Farm Protection Act.
Better CARE for Animals Act of 2025
Client: HUMANE WORLD ACTION FUND (FKA HUMANE SOCIETY LEGISLATIVE FUND) · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to animal welfare, including H.R. 3732 - BARK Act, H.R. 3112/S. 1538 Better CARE for Animals Act of 2025, and Fiscal Year 2026 appropriations language regarding wild horses and burros; Issues related to S. 1326 - Food Security and Farm Protection Act.
Patent Eligibility Restoration Act of 2025
Client: COALITION FOR 21ST CENTURY PATENT REFORM · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to patent reform legislation; Issues related to H.R. 3152/S.1546 - Patent Eligibility Restoration Act of 2025; Issues related to H.R. 3160/S. 1553 - PREVAIL Act.
PREVAIL Act
Client: COALITION FOR 21ST CENTURY PATENT REFORM · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to patent reform legislation; Issues related to H.R. 3152/S.1546 - Patent Eligibility Restoration Act of 2025; Issues related to H.R. 3160/S. 1553 - PREVAIL Act.
Issues related to predatory and deceptive practices in the ticketing market, including H.R. 1402/S. 281 - TICKET Act; S. 196 - MAIN Event Ticketing Act.
MAIN Event Ticketing Act
Client: NATIONAL INDEPENDENT VENUE ASSOCIATION · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to predatory and deceptive ticketing practices, including H.R. 1402/S. 281 - TICKET Act; S. 196 - MAIN Event Ticketing Act.
MAIN Event Ticketing Act
Client: NATIONAL INDEPENDENT VENUE ASSOCIATION · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to predatory and deceptive practices in the ticketing market, including H.R. 1402/S. 281 - TICKET Act, and H.R. 2713/S. 196 - MAIN Event Ticketing Act.
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: SHATTERPROOF · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to Substance Use Disorder programs; H.R. 2483/S. 2121 - SUPPORT for Patients and Communities Reauthorization Act of 2025; Issues related to H.R. 5281 - REAL Health Providers Act; Issues related to behavioral health; Issues related to the Substance Abuse and Mental Health Services Administration's mental health and addiction treatment locator, FindTreatment.gov, and including quality indicators for addiction treatment.
Issues related to predatory and deceptive practices in the ticketing market, including H.R. 1402/S. 281 - TICKET Act; S. 196 - MAIN Event Ticketing Act.
TICKET Act
Client: NATIONAL INDEPENDENT VENUE ASSOCIATION · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to predatory and deceptive practices in the ticketing market, including H.R. 1402/S. 281 - TICKET Act, and H.R. 2713/S. 196 - MAIN Event Ticketing Act.
TICKET Act
Client: NATIONAL INDEPENDENT VENUE ASSOCIATION · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to predatory and deceptive ticketing practices, including H.R. 1402/S. 281 - TICKET Act; S. 196 - MAIN Event Ticketing Act.
Give Kids a Chance Act of 2025
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to PAHPA reauthorization; Rare Pediatric Disease Priority Review Voucher Program reauthorization (H.R. 1262/S. 932 - Give Kids a Chance Act of 2025).
Give Kids a Chance Act of 2025
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to Rare Pediatric Disease Priority Review Voucher Program reauthorization; Issues related to H.R. 1262/S. 932 - Give Kids a Chance Act of 2025; Issues related to biotechnology innovation ecosystems.
Give Kids a Chance Act of 2025
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to Rare Pediatric Disease Priority Review Voucher Program reauthorization; Issues related to H.R. 1262/S. 932 - Give Kids a Chance Act of 2025.
Give Kids a Chance Act of 2025
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to Rare Pediatric Disease Priority Review Voucher Program reauthorization; H.R. 1262/S. 932 - Give Kids a Chance Act of 2025.
To amend title XVIII of the Social Security Act to require MA organizations offering network-based plans to maintain an accurate provider directory, and for other purposes.
Client: SHATTERPROOF · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to Substance Use Disorder programs; SUPPORT Act reauthorization; Issues related to behavioral health; H.R. 7708/S. 3059 - REAL Health Providers Act (118th Congress).
Issues related to Substance Use Disorder programs; SUPPORT Act reauthorization; Issues related to behavioral health; H.R. 7708/S. 3059 - REAL Health Providers Act (118th Congress).
Issues related to strengthening and securing U.S. pharmaceutical manufacturing supply chains in S.4638 - National Defense Authorization Act for Fiscal Year 2025 and H.R.8070 - Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025; H.R.10545 - American Relief Act, 2025 (PL 118-158).
Issues related to strengthening and securing U.S. pharmaceutical manufacturing supply chains in S.4638 - National Defense Authorization Act for Fiscal Year 2025 and H.R.8070 - Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025; H.R.10545 - American Relief Act, 2025 (PL 118-158).
Issues related to foreign and humanitarian assistance including H.R. 1570/S. 767 - MINDS Act.
Pro Codes Act
Client: NATIONAL FIRE PROTECTION ASSOCIATION · Firm: AKIN GUMP STRAUSS HAUER & FELD
H.R. 1631/S. 835 - Pro Codes Act.
Defending Domestic Orange Juice Production Act of 2023
Client: FLORIDA CITRUS MUTUAL · Firm: AKIN GUMP STRAUSS HAUER & FELD
S. 103/H.R. 1750 - Defending Domestic Orange Juice Production Act of 2023; 2023 Farm Bill.
FY 2024 Appropriations; funding for recovery housing and substance use disorders (SUD); expanding access to Medication-Assisted Treatment (MAT); mental health and SUD legislation; H.R.4088/S.1991 - CAREER Act of 2023; H.R.2400/S.1165 - Reentry Act of 2023; S. 3393 - SUPPORT for Patients and Communities Reauthorization Act; and H.R.4531 - The Support for Patients and Communities Reauthorization (SUPPORT) Act of 2023.
FAA Reauthorization Act of 2024
Client: BOOZ ALLEN HAMILTON INC. · Firm: AKIN GUMP STRAUSS HAUER & FELD
Safety issues related to H.R.3935/S. 1939 - FAA Reauthorization Act of 2024.
FAA Reauthorization Act of 2024
Client: BOOZ ALLEN HAMILTON INC. · Firm: AKIN GUMP STRAUSS HAUER & FELD
Safety issues related to H.R.3935/S. 1939 - FAA Reauthorization Act of 2024.
FAA Reauthorization Act of 2024
Client: BOOZ ALLEN HAMILTON INC. · Firm: AKIN GUMP STRAUSS HAUER & FELD
Safety issues related to H.R.3935/S. 1939 - FAA Reauthorization Act of 2024.
TICKET Act
Client: NATIONAL INDEPENDENT VENUE ASSOCIATION · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to predatory and deceptive ticketing practices; S. 3457 - the Fans First Act; H.R. 3950/S. 1303 - Transparency In Charges for Key Events Ticketing Act (TICKET Act).
FY 2024 Appropriations; funding for recovery housing and substance use disorders (SUD); expanding access to Medication-Assisted Treatment (MAT); mental health and SUD legislation; H.R.4088/S.1991 - CAREER Act of 2023; H.R.2400/S.1165 - Reentry Act of 2023; S. 3393 - SUPPORT for Patients and Communities Reauthorization Act; and H.R.4531 - The Support for Patients and Communities Reauthorization (SUPPORT) Act of 2023.
PREVAIL Act
Client: COALITION FOR 21ST CENTURY PATENT REFORM · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to patent reform legislation. S. 2140 - Patent Eligibility Restoration (PERA) Act of 2023 and H.R. 4370/S. 2220 - Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act.
PREVAIL Act
Client: COALITION FOR 21ST CENTURY PATENT REFORM · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to patent reform legislation. S. 2140 - Patent Eligibility Restoration (PERA) Act of 2023 and H.R. 4370/S. 2220 - Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act.
Preparing for All Hazards and Pathogens Reauthorization Act
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: AKIN GUMP STRAUSS HAUER & FELD
Pandemic and All-Hazards Preparedness Act (PL 109-417) reauthorization (S. 2333 - Pandemic and All-Hazards Preparedness and Response Act; H.R. 4421 - Preparing for All Hazards and Pathogens Reauthorization Act); drug pricing issues; PBM reform (S. 2973 - Modernizing and Ensuring PBM Accountability Act; S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023); H.R. 7384/S. 4583 - Rare Pediatric Priority Review Voucher Program reauthorization; S. 2305 - the Biosimilar Red Tape Elimination Act; H.R.5429/S. 2780 - the Medication Affordability and Patent Integrity Act.
Preparing for All Hazards and Pathogens Reauthorization Act
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: AKIN GUMP STRAUSS HAUER & FELD
Pandemic and All-Hazards Preparedness Act (PL 109-417) reauthorization (S. 2333 - Pandemic and All-Hazards Preparedness and Response Act; H.R. 4421 - Preparing for All Hazards and Pathogens Reauthorization Act); drug pricing issues; PBM reform (S. 2973 - Modernizing and Ensuring PBM Accountability Act; S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023); National Vaccine Injury Compensation Program; Medicaid drug rebate program; Rare Pediatric Priority Review Voucher Program reauthorization.
Preparing for All Hazards and Pathogens Reauthorization Act
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: AKIN GUMP STRAUSS HAUER & FELD
Pandemic and All-Hazards Preparedness Act (PL 109-417) reauthorization (S. 2333 - Pandemic and All-Hazards Preparedness and Response Act; H.R. 4421 - Preparing for All Hazards and Pathogens Reauthorization Act); drug pricing issues; PBM reform (S. 2973 - Modernizing and Ensuring PBM Accountability Act; S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023); H.R. 7384/S. 4583 - Rare Pediatric Priority Review Voucher Program reauthorization.
Preparing for All Hazards and Pathogens Reauthorization Act
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: AKIN GUMP STRAUSS HAUER & FELD
PAHPA reauthorization (S. 2333 - Pandemic and All-Hazards Preparedness and Response Act; H.R. 4421 - the Preparing for All Hazards and Pathogens Reauthorization Act); Drug pricing issues; PBM reform (S. 2973 -Modernizing and Ensuring PBM Accountability Act and S. 3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023); Rare Pediatric Disease Priority Review Voucher Program reauthorization (H.R. 7384/ S. 4583 - Creating Hope Reauthorization Act); National Vaccine Injury Compensation Program.
Support for Patients and Communities Reauthorization Act
Client: SHATTERPROOF · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health and Substance Use Disorder programs; H.R. 4531/S. 2433 - SUPPORT for Patients and Communities Reauthorization Act; H.R. 5819/S. 1378 - COMPLETE Care Act; H.R. 7708/S. 3059 - REAL Health Providers Act; H.R. 8028/S. 4477 - Second Chance Reauthorization Act.
Support for Patients and Communities Reauthorization Act
Client: SHATTERPROOF · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health and Substance Use Disorder programs; H.R. 4531/S. 2433 - SUPPORT for Patients and Communities Reauthorization Act; H.R. 5819/S. 1378 - COMPLETE Care Act; H.R. 7708/S. 3059 - REAL Health Providers Act; H.R. 8028/S. 4477 - Second Chance Reauthorization Act.
Support for Patients and Communities Reauthorization Act
Client: SHATTERPROOF · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health and Substance Use Disorder programs; H.R. 4531/S. 2433 - SUPPORT for Patients and Communities Reauthorization Act; H.R. 5819/S. 1378 - COMPLETE Care Act; H.R. 7708/S. 3059 - REAL Health Providers Act; H.R. 8028/S. 4477 - Second Chance Reauthorization Act.
Support for Patients and Communities Reauthorization Act
Client: FLETCHER GROUP, INC. · Firm: AKIN GUMP STRAUSS HAUER & FELD
FY 2024 Appropriations; funding for recovery housing and substance use disorders (SUD); expanding access to Medication-Assisted Treatment (MAT); mental health and SUD legislation; H.R.4088/S.1991 - CAREER Act of 2023; H.R.2400/S.1165 - Reentry Act of 2023; S. 3393 - SUPPORT for Patients and Communities Reauthorization Act; and H.R.4531 - The Support for Patients and Communities Reauthorization (SUPPORT) Act of 2023.
Medication Affordability and Patent Integrity Act
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: AKIN GUMP STRAUSS HAUER & FELD
Pandemic and All-Hazards Preparedness Act (PL 109-417) reauthorization (S. 2333 - Pandemic and All-Hazards Preparedness and Response Act; H.R. 4421 - Preparing for All Hazards and Pathogens Reauthorization Act); drug pricing issues; PBM reform (S. 2973 - Modernizing and Ensuring PBM Accountability Act; S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023); H.R. 7384/S. 4583 - Rare Pediatric Priority Review Voucher Program reauthorization; S. 2305 - the Biosimilar Red Tape Elimination Act; H.R.5429/S. 2780 - the Medication Affordability and Patent Integrity Act.
Connecting Our Medical Providers with Links to Expand Tailored and Effective Care Act
Client: SHATTERPROOF · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health and Substance Use Disorder programs; H.R. 4531/S. 2433 - SUPPORT for Patients and Communities Reauthorization Act; H.R. 5819/S. 1378 - COMPLETE Care Act; H.R. 7708/S. 3059 - REAL Health Providers Act; H.R. 8028/S. 4477 - Second Chance Reauthorization Act.
Connecting Our Medical Providers with Links to Expand Tailored and Effective Care Act
Client: SHATTERPROOF · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health and Substance Use Disorder programs; H.R. 4531/S. 2433 - SUPPORT for Patients and Communities Reauthorization Act; H.R. 5819/S. 1378 - COMPLETE Care Act; H.R. 7708/S. 3059 - REAL Health Providers Act; H.R. 8028/S. 4477 - Second Chance Reauthorization Act.
Connecting Our Medical Providers with Links to Expand Tailored and Effective Care Act
Client: SHATTERPROOF · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to Substance Use Disorder programs; S. 2433 - SUPPORT for Patients and Communities Reauthorization Act of 2023 funding; Issues related to behavioral health, including S. 1378/H.R. 5819 - COMPLETE Care Act; and S. 3059/H.R. 7708 - REAL Health Providers Act.
Connecting Our Medical Providers with Links to Expand Tailored and Effective Care Act
Client: SHATTERPROOF · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health and Substance Use Disorder programs; H.R. 4531/S. 2433 - SUPPORT for Patients and Communities Reauthorization Act; H.R. 5819/S. 1378 - COMPLETE Care Act; H.R. 7708/S. 3059 - REAL Health Providers Act; H.R. 8028/S. 4477 - Second Chance Reauthorization Act.
Prohibiting Nationalization of American Companies and Investments Act of 2023
Client: VEON LTD. · Firm: AKIN GUMP STRAUSS HAUER & FELD
Discuss issues related to the business regarding Ukraine and Russia; H.R. 6682/S. 3269 - Prohibiting Nationalization of American Companies and Investments Act of 2023.
Prohibiting Nationalization of American Companies and Investments Act of 2023
Client: VEON LTD. · Firm: AKIN GUMP STRAUSS HAUER & FELD
Discuss issues related to the business regarding Ukraine and Russia; H.R. 6682/S. 3269 - Prohibiting Nationalization of American Companies and Investments Act of 2023.
Prohibiting Nationalization of American Companies and Investments Act of 2023
Client: VEON LTD. · Firm: AKIN GUMP STRAUSS HAUER & FELD
Discuss issues related to the business regarding Ukraine and Russia; H.R. 6682/S. 3269 - Prohibiting Nationalization of American Companies and Investments Act of 2023.
Creating Hope Reauthorization Act of 2024
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: AKIN GUMP STRAUSS HAUER & FELD
Pandemic and All-Hazards Preparedness Act (PL 109-417) reauthorization (S. 2333 - Pandemic and All-Hazards Preparedness and Response Act; H.R. 4421 - Preparing for All Hazards and Pathogens Reauthorization Act); drug pricing issues; PBM reform (S. 2973 - Modernizing and Ensuring PBM Accountability Act; S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023); H.R. 7384/S. 4583 - Rare Pediatric Priority Review Voucher Program reauthorization.
Creating Hope Reauthorization Act of 2024
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: AKIN GUMP STRAUSS HAUER & FELD
PAHPA reauthorization (S. 2333 - Pandemic and All-Hazards Preparedness and Response Act; H.R. 4421 - the Preparing for All Hazards and Pathogens Reauthorization Act); Drug pricing issues; PBM reform (S. 2973 -Modernizing and Ensuring PBM Accountability Act and S. 3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023); Rare Pediatric Disease Priority Review Voucher Program reauthorization (H.R. 7384/ S. 4583 - Creating Hope Reauthorization Act); National Vaccine Injury Compensation Program.
Creating Hope Reauthorization Act of 2024
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: AKIN GUMP STRAUSS HAUER & FELD
Pandemic and All-Hazards Preparedness Act (PL 109-417) reauthorization (S. 2333 - Pandemic and All-Hazards Preparedness and Response Act; H.R. 4421 - Preparing for All Hazards and Pathogens Reauthorization Act); drug pricing issues; PBM reform (S. 2973 - Modernizing and Ensuring PBM Accountability Act; S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023); H.R. 7384/S. 4583 - Rare Pediatric Priority Review Voucher Program reauthorization; S. 2305 - the Biosimilar Red Tape Elimination Act; H.R.5429/S. 2780 - the Medication Affordability and Patent Integrity Act.
To amend title XVIII of the Social Security Act to require MA organizations offering network-based plans to maintain an accurate provider directory, and for other purposes.
Client: SHATTERPROOF · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health and Substance Use Disorder programs; H.R. 4531/S. 2433 - SUPPORT for Patients and Communities Reauthorization Act; H.R. 5819/S. 1378 - COMPLETE Care Act; H.R. 7708/S. 3059 - REAL Health Providers Act; H.R. 8028/S. 4477 - Second Chance Reauthorization Act.
To amend title XVIII of the Social Security Act to require MA organizations offering network-based plans to maintain an accurate provider directory, and for other purposes.
Client: SHATTERPROOF · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health and Substance Use Disorder programs; H.R. 4531/S. 2433 - SUPPORT for Patients and Communities Reauthorization Act; H.R. 5819/S. 1378 - COMPLETE Care Act; H.R. 7708/S. 3059 - REAL Health Providers Act; H.R. 8028/S. 4477 - Second Chance Reauthorization Act.
To amend title XVIII of the Social Security Act to require MA organizations offering network-based plans to maintain an accurate provider directory, and for other purposes.
Client: SHATTERPROOF · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to Substance Use Disorder programs; S. 2433 - SUPPORT for Patients and Communities Reauthorization Act of 2023 funding; Issues related to behavioral health, including S. 1378/H.R. 5819 - COMPLETE Care Act; and S. 3059/H.R. 7708 - REAL Health Providers Act.
To amend title XVIII of the Social Security Act to require MA organizations offering network-based plans to maintain an accurate provider directory, and for other purposes.
Client: SHATTERPROOF · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health and Substance Use Disorder programs; H.R. 4531/S. 2433 - SUPPORT for Patients and Communities Reauthorization Act; H.R. 5819/S. 1378 - COMPLETE Care Act; H.R. 7708/S. 3059 - REAL Health Providers Act; H.R. 8028/S. 4477 - Second Chance Reauthorization Act.
Second Chance Reauthorization Act of 2024
Client: SHATTERPROOF · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health and Substance Use Disorder programs; H.R. 4531/S. 2433 - SUPPORT for Patients and Communities Reauthorization Act; H.R. 5819/S. 1378 - COMPLETE Care Act; H.R. 7708/S. 3059 - REAL Health Providers Act; H.R. 8028/S. 4477 - Second Chance Reauthorization Act.
Second Chance Reauthorization Act of 2024
Client: SHATTERPROOF · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health and Substance Use Disorder programs; H.R. 4531/S. 2433 - SUPPORT for Patients and Communities Reauthorization Act; H.R. 5819/S. 1378 - COMPLETE Care Act; H.R. 7708/S. 3059 - REAL Health Providers Act; H.R. 8028/S. 4477 - Second Chance Reauthorization Act.
Second Chance Reauthorization Act of 2024
Client: SHATTERPROOF · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health and Substance Use Disorder programs; H.R. 4531/S. 2433 - SUPPORT for Patients and Communities Reauthorization Act; H.R. 5819/S. 1378 - COMPLETE Care Act; H.R. 7708/S. 3059 - REAL Health Providers Act; H.R. 8028/S. 4477 - Second Chance Reauthorization Act.
Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025
Client: BAIN CAPITAL, LLC · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to strengthening and securing U.S. pharmaceutical manufacturing supply chains in S.4638 - National Defense Authorization Act for Fiscal Year 2025 and H.R.8070 - Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025; H.R.10545 - American Relief Act, 2025 (PL 118-158).
Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025
Client: BAIN CAPITAL, LLC · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to strengthening and securing U.S. pharmaceutical manufacturing supply chains in S.4638 - National Defense Authorization Act for Fiscal Year 2025 and H.R.8070 - Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025; H.R.10545 - American Relief Act, 2025 (PL 118-158).
Protecting Student Athletes’ Economic Freedom Act of 2024
Client: SOUTHEASTERN CONFERENCE · Firm: AKIN GUMP STRAUSS HAUER & FELD
Legislation regarding student athletes and college athletics; S.2495 - Protecting Athletes, Schools, and Sports Act of 2023; H.R. 8534 - Protecting Student Athletes Economic Freedom Act.
Protecting Student Athletes’ Economic Freedom Act of 2024
Client: SOUTHEASTERN CONFERENCE · Firm: AKIN GUMP STRAUSS HAUER & FELD
Legislation regarding student athletes and college athletics; S.2495 - Protecting Athletes, Schools, and Sports Act of 2023; H.R. 8534 - Protecting Student Athletes Economic Freedom Act.
Protecting Student Athletes’ Economic Freedom Act of 2024
Client: SOUTHEASTERN CONFERENCE · Firm: AKIN GUMP STRAUSS HAUER & FELD
Legislation regarding student athletes and college athletics; S.2495 - Protecting Athletes, Schools, and Sports Act of 2023; H.R. 8534 - Protecting Student Athletes Economic Freedom Act.
Renewed Hope Act of 2024
Client: THE TIM TEBOW FOUNDATION · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to human trafficking and child exploitation, including H.R. 9523/ S. 5015 - Renewed Hope Act of 2024.
Defending Domestic Orange Juice Production Act of 2023
Client: FLORIDA CITRUS MUTUAL · Firm: AKIN GUMP STRAUSS HAUER & FELD
S. 103/H.R. 1750 - Defending Domestic Orange Juice Production Act of 2023; 2023 Farm Bill.
FY 2024 Appropriations; funding for recovery housing and substance use disorders (SUD); expanding access to Medication-Assisted Treatment (MAT); mental health and SUD legislation; H.R.4088/S.1991 - CAREER Act of 2023; H.R.2400/S.1165 - Reentry Act of 2023; S. 3393 - SUPPORT for Patients and Communities Reauthorization Act; and H.R.4531 - The Support for Patients and Communities Reauthorization (SUPPORT) Act of 2023.
TICKET Act
Client: NATIONAL INDEPENDENT VENUE ASSOCIATION · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to predatory and deceptive ticketing practices; S. 3457 - the Fans First Act; H.R. 3950/S. 1303 - Transparency In Charges for Key Events Ticketing Act (TICKET Act).
Connecting Our Medical Providers with Links to Expand Tailored and Effective Care
Client: SHATTERPROOF · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to Substance Use Disorder programs; S. 2433 - SUPPORT for Patients and Communities Reauthorization Act of 2023 funding; Issues related to behavioral health, including S. 1378/H.R. 5819 - COMPLETE Care Act; and S. 3059/H.R. 7708 - REAL Health Providers Act.
Connecting Our Medical Providers with Links to Expand Tailored and Effective Care
Client: SHATTERPROOF · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health and Substance Use Disorder programs; H.R. 4531/S. 2433 - SUPPORT for Patients and Communities Reauthorization Act; H.R. 5819/S. 1378 - COMPLETE Care Act; H.R. 7708/S. 3059 - REAL Health Providers Act; H.R. 8028/S. 4477 - Second Chance Reauthorization Act.
Issues related to distributor-supported service models and related policy.
COALITION OF SEMICONDUCTOR EQUIPMENT MANUFACTURERS via AKIN GUMP STRAUSS HAUER & FELD
2026 · second_quarter · Q2
Issues related to U.S. export control policy.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
KOHLBERG KRAVIS ROBERTS & COMPANY via AKIN GUMP STRAUSS HAUER & FELD
2026 · second_quarter · Q2
Issues related to economic policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SHATTERPROOF via AKIN GUMP STRAUSS HAUER & FELD
2026 · second_quarter · Q2
Issues related to Substance Use Disorder programs; Issues related to SUPPORT for Patients and Communities Reauthorization Act of 2025 (P.L. 119-44) funding; Issues related to H.R. 2509/S. 931 - COMPLETE Care Act; Issues related to behavioral health; Issues related to the Substance Abuse and Mental Health Services Administration's mental health and addiction treatment locator, FindTreatment.gov, and including quality indicators for addiction treatment.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OPENAI OPCO, LLC via AKIN GUMP STRAUSS HAUER & FELD
2026 · second_quarter · Q2
Issues related to artificial intelligence legislation and regulation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL INDEPENDENT VENUE ASSOCIATION via AKIN GUMP STRAUSS HAUER & FELD
2026 · second_quarter · Q2
Issues related to predatory and deceptive practices in the ticketing market.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN AIRLINES, INC via AKIN GUMP STRAUSS HAUER & FELD
2026 · second_quarter · Q2
Issues related to the aviation industry.
Issues related to credit card interchange fees.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FAIR ISAAC CORPORATION (FICO) via AKIN GUMP STRAUSS HAUER & FELD
2026 · second_quarter · Q2
Issues related to credit scores.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ANHEUSER-BUSCH COMPANIES, INC. via AKIN GUMP STRAUSS HAUER & FELD
2026 · second_quarter · Q2
Issues related to tax incentives in support of grown in America products.
Issues related to H.R. 1707 - Grown in America Act of 2025.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
SOUTHEASTERN CONFERENCE via AKIN GUMP STRAUSS HAUER & FELD
2026 · second_quarter · 2T
Issues related to student athletes and college athletics, including H.R. 4312 - SCORE Act, and S.____ - College Sports Competitive Act.
Filing targets: Education, Dept of, HOUSE OF REPRESENTATIVES, SENATE, White House Office
AMERILIFE GROUP, LLC via AKIN GUMP STRAUSS HAUER & FELD
2026 · second_quarter · Q2
Issues related to Medicare Advantage compensation and agent and broker policies; Issues related to MedPAC nominations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VANTIVE US HEALTHCARE LLC via AKIN GUMP STRAUSS HAUER & FELD
2026 · second_quarter · Q2
Issues related to Medicare and provider reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES
KIPP FOUNDATION via AKIN GUMP STRAUSS HAUER & FELD
2026 · second_quarter · Q2
Issues related to federal funding for the Charter School Program (CSP) and policies that support public charter education.
Filing targets: HOUSE OF REPRESENTATIVES
ENTERGY SERVICES, LLC via AKIN GUMP STRAUSS HAUER & FELD
2026 · second_quarter · Q2
Issues related to utilities.
Issues related to utilities.
Filing targets: HOUSE OF REPRESENTATIVES
BOOZ ALLEN HAMILTON INC. via AKIN GUMP STRAUSS HAUER & FELD
2026 · second_quarter · Q2
Issues related to aviation safety improvements.
Issues related to Recreation.gov.
Issues related to aviation safety improvements.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIOTECHNOLOGY INNOVATION ORGANIZATION via AKIN GUMP STRAUSS HAUER & FELD
2026 · second_quarter · Q2
Issues related to Rare Pediatric Disease Priority Review Voucher Program reauthorization; Issues related to H.R. 1262 / S. 3302 - Mikaela Naylon Give Kids a Chance Act of 2025; Issues related to the Consolidated Appropriations Act, 2026 (P.L. 119-75), including the extension of authority to issue priority review vouchers to encourage treatments for rare pediatric diseases; Issues related to the biotech ecosystem, including most-favored-nation drug pricing; Issues related to PBM reform, PAHPA reauthorization; and PDUFA reauthorization.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALTRIA CLIENT SERVICES LLC via AKIN GUMP STRAUSS HAUER & FELD
2026 · second_quarter · Q2
Issues related to tobacco harm reduction efforts and combatting the proliferation of illicit electronic nicotine products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BOOZ ALLEN HAMILTON INC. via AKIN GUMP STRAUSS HAUER & FELD
2026 · first_quarter · Q1
Issues related to Recreation.gov.
Issues related to aviation safety improvements.
Issues related to aviation safety improvements.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SAP AMERICA, INC. via AKIN GUMP STRAUSS HAUER & FELD
2026 · first_quarter · Q1
Issues related to artificial intelligence and data privacy legislation; Issues related to cybersecurity.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
VANTIVE US HEALTHCARE LLC via AKIN GUMP STRAUSS HAUER & FELD
2026 · first_quarter · Q1
Issues related to Medicare and provider reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES
KIPP FOUNDATION via AKIN GUMP STRAUSS HAUER & FELD
2026 · first_quarter · Q1
Issues related to federal funding for the Charter School Program (CSP) and policies that support public charter education.
Filing targets: HOUSE OF REPRESENTATIVES
ENTERGY SERVICES, LLC via AKIN GUMP STRAUSS HAUER & FELD
2026 · first_quarter · Q1
Issues related to utilities.
Issues related to utilities.
Filing targets: HOUSE OF REPRESENTATIVES
EDUCATION REFORM NOW ADVOCACY via AKIN GUMP STRAUSS HAUER & FELD
2026 · first_quarter · 1T
Issues related to education reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SOUTHEASTERN CONFERENCE via AKIN GUMP STRAUSS HAUER & FELD
2026 · first_quarter · Q1
Issues related to student athletes and college athletics, including H.R. 4312 - SCORE Act, and S.____ - College Sports Competitive Act.
Filing targets: Education, Dept of, HOUSE OF REPRESENTATIVES, SENATE, White House Office
SHATTERPROOF via AKIN GUMP STRAUSS HAUER & FELD
2026 · first_quarter · Q1
Issues related to Substance Use Disorder programs; SUPPORT for Patients and Communities Reauthorization Act of 2025 (P.L. 119-44); Issues related to H.R. 5281/S. 3750 - REAL Health Providers Act; Issues related to H.R. 2509/S. 931 - COMPLETE Care Act; Issues related to behavioral health; Issues related to the Substance Abuse and Mental Health Services Administration's mental health and addiction treatment locator, FindTreatment.gov, and including quality indicators for addiction treatment.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIOTECHNOLOGY INNOVATION ORGANIZATION via AKIN GUMP STRAUSS HAUER & FELD
2026 · first_quarter · Q1
Issues related to Rare Pediatric Disease Priority Review Voucher Program reauthorization; Issues related to H.R. 1262/S. 3302 - Mikaela Naylon Give Kids a Chance Act of 2025; Issues related to the Consolidated Appropriations Act, 2026 (P.L. 119-75), including the extension of authority to issue priority review vouchers to encourage treatments for rare pediatric diseases.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALTRIA CLIENT SERVICES LLC via AKIN GUMP STRAUSS HAUER & FELD
2026 · first_quarter · Q1
Issues related to tobacco harm reduction efforts and combatting the proliferation of illicit electronic nicotine products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KOHLBERG KRAVIS ROBERTS & COMPANY via AKIN GUMP STRAUSS HAUER & FELD
2026 · first_quarter · Q1
Issues related to economic policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SALESFORCE.COM, INC via AKIN GUMP STRAUSS HAUER & FELD
2026 · first_quarter · 1T
Issues related to artificial intelligence, privacy, and data security.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OPENAI OPCO, LLC via AKIN GUMP STRAUSS HAUER & FELD
2026 · first_quarter · Q1
Issues related to artificial intelligence legislation and regulation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTERACTIVE ADVERTISING BUREAU via AKIN GUMP STRAUSS HAUER & FELD
2026 · first_quarter · Q1
Issues related to digital advertising.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FAIR ISAAC CORPORATION (FICO) via AKIN GUMP STRAUSS HAUER & FELD
2026 · first_quarter · Q1
Issues related to credit scores.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMVCO, LLC via AKIN GUMP STRAUSS HAUER & FELD
2026 · first_quarter · Q1
Issues related to the role and responsibility of setting global payment standards to ensure interoperability and acceptance of secure payment transactions.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ANHEUSER-BUSCH COMPANIES, INC. via AKIN GUMP STRAUSS HAUER & FELD
2026 · first_quarter · Q1
Issues related to tax incentives in support of grown in America products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
AMERILIFE GROUP, LLC via AKIN GUMP STRAUSS HAUER & FELD
2026 · first_quarter · Q1
Issues related to Medicare Advantage compensation and agent and broker policies; Issues related to MedPAC nominations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN AIRLINES, INC via AKIN GUMP STRAUSS HAUER & FELD
2026 · first_quarter · Q1
Issues related to credit card interchange fees.
Issues related to the aviation industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
1-800 CONTACTS via AKIN GUMP STRAUSS HAUER & FELD
2026 · first_quarter · Q1
Issues related to the Federal Trade Commission Contact Lens Rule.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TI CAPITAL MANAGEMENT, LLC via AKIN GUMP STRAUSS HAUER & FELD
2026 · first_quarter · RR
Issues related to investments in Djibouti.
Issues related to investments in Djibouti.
SOUTHEASTERN CONFERENCE via AKIN GUMP STRAUSS HAUER & FELD
2025 · fourth_quarter · Q4
Issues related to student athletes and college athletics; Issues related to H.R. 4312 - SCORE Act.
Filing targets: Education, Dept of, HOUSE OF REPRESENTATIVES, SENATE, White House Office
SALESFORCE.COM, INC via AKIN GUMP STRAUSS HAUER & FELD
2025 · fourth_quarter · Q4
Issues related to artificial intelligence, privacy, and data security.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VANTIVE US HEALTHCARE LLC via AKIN GUMP STRAUSS HAUER & FELD
2025 · fourth_quarter · Q4
Issues related to Medicare and provider reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES
BIOTECHNOLOGY INNOVATION ORGANIZATION via AKIN GUMP STRAUSS HAUER & FELD
2025 · fourth_quarter · Q4
Issues related to Rare Pediatric Disease Priority Review Voucher Program reauthorization; Issues related to H.R. 1262/S. 932 - Give Kids a Chance Act of 2025; Issues related to biotechnology innovation ecosystems.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OPENAI OPCO, LLC via AKIN GUMP STRAUSS HAUER & FELD
2025 · fourth_quarter · Q4
Issues related to Artificial Intelligence legislation and regulation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KIPP FOUNDATION via AKIN GUMP STRAUSS HAUER & FELD
2025 · fourth_quarter · Q4
Issues related to federal funding for the Charter School Program (CSP) and policies that support public charter education.
Filing targets: HOUSE OF REPRESENTATIVES
ENTERGY SERVICES, LLC via AKIN GUMP STRAUSS HAUER & FELD
2025 · fourth_quarter · Q4
Issues related to utilities.
Issues related to utilities.
Filing targets: HOUSE OF REPRESENTATIVES
EDUCATION REFORM NOW ADVOCACY via AKIN GUMP STRAUSS HAUER & FELD
2025 · fourth_quarter · Q4
Issues related to education reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MICROSOFT CORPORATION via AKIN GUMP STRAUSS HAUER & FELD
2025 · fourth_quarter · Q4
Issues related to technology and artificial intelligence.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BOOZ ALLEN HAMILTON INC. via AKIN GUMP STRAUSS HAUER & FELD
2025 · fourth_quarter · Q4
Issues related to federal contracting.
Filing targets: HOUSE OF REPRESENTATIVES
ALTRIA CLIENT SERVICES LLC via AKIN GUMP STRAUSS HAUER & FELD
2025 · fourth_quarter · Q4
Issues related to tobacco harm reduction efforts.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SHATTERPROOF via AKIN GUMP STRAUSS HAUER & FELD
2025 · fourth_quarter · Q4
Issues related to Substance Use Disorder programs; SUPPORT for Patients and Communities Reauthorization Act of 2025 (P.L. 119-44); Issues related to H.R. 5281 - REAL Health Providers Act; Issues related to behavioral health; Issues related to the Substance Abuse and Mental Health Services Administration's mental health and addiction treatment locator, FindTreatment.gov, and including quality indicators for addiction treatment; Issues related to regulating intoxicating hemp products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN AIRLINES, INC via AKIN GUMP STRAUSS HAUER & FELD
2025 · fourth_quarter · Q4
Issues related to the aviation industry.
Issues related to credit card interchange fees.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KYVERNA THERAPEUTICS, INC. via AKIN GUMP STRAUSS HAUER & FELD
2025 · fourth_quarter · RR
Issues related to developing cell therapies for patients.
AMERICAN AIRLINES, INC via AKIN GUMP STRAUSS HAUER & FELD
2025 · third_quarter · Q3
Issues related to the aviation industry.
Issues related to credit card interchange fees.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SALESFORCE.COM, INC via AKIN GUMP STRAUSS HAUER & FELD
2025 · third_quarter · Q3
Issues related to artificial intelligence, privacy, and data security.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OPENAI OPCO, LLC via AKIN GUMP STRAUSS HAUER & FELD
2025 · third_quarter · Q3
Issues related to Artificial Intelligence legislation and regulation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MICROSOFT CORPORATION via AKIN GUMP STRAUSS HAUER & FELD
2025 · third_quarter · Q3
Issues related to technology and artificial intelligence.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FAIR ISAAC CORPORATION (FICO) via AKIN GUMP STRAUSS HAUER & FELD
2025 · third_quarter · Q3
Issues related to credit scores.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SHATTERPROOF via AKIN GUMP STRAUSS HAUER & FELD
2025 · third_quarter · Q3
Issues related to Substance Use Disorder programs; H.R. 2483/S. 2121 - SUPPORT for Patients and Communities Reauthorization Act of 2025; Issues related to H.R. 5281 - REAL Health Providers Act; Issues related to behavioral health; Issues related to the Substance Abuse and Mental Health Services Administration's mental health and addiction treatment locator, FindTreatment.gov, and including quality indicators for addiction treatment.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VANTIVE US HEALTHCARE LLC via AKIN GUMP STRAUSS HAUER & FELD
2025 · third_quarter · Q3
Issues related to Medicare and provider reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES
KIPP FOUNDATION via AKIN GUMP STRAUSS HAUER & FELD
2025 · third_quarter · Q3
Issues related to federal funding for the Charter School Program (CSP) and policies that support public charter education.
Filing targets: HOUSE OF REPRESENTATIVES
ENTERGY SERVICES, LLC via AKIN GUMP STRAUSS HAUER & FELD
2025 · third_quarter · Q3
Issues related to utilities.
Issues related to utilities.
Filing targets: HOUSE OF REPRESENTATIVES
EDUCATION REFORM NOW ADVOCACY via AKIN GUMP STRAUSS HAUER & FELD
2025 · third_quarter · Q3
Issues related to education reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BOOZ ALLEN HAMILTON INC. via AKIN GUMP STRAUSS HAUER & FELD
2025 · third_quarter · Q3
Issues related to federal contracting.
Issues related to the FEMA National Exercise Program.
Filing targets: HOUSE OF REPRESENTATIVES
SOUTHEASTERN CONFERENCE via AKIN GUMP STRAUSS HAUER & FELD
2025 · third_quarter · Q3
Issues related to student athletes and college athletics; Issues related to H.R. 4312 - SCORE Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
BIOTECHNOLOGY INNOVATION ORGANIZATION via AKIN GUMP STRAUSS HAUER & FELD
2025 · third_quarter · Q3
Issues related to Rare Pediatric Disease Priority Review Voucher Program reauthorization; Issues related to H.R. 1262/S. 932 - Give Kids a Chance Act of 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALTRIA CLIENT SERVICES LLC via AKIN GUMP STRAUSS HAUER & FELD
2025 · third_quarter · Q3
Issues related to compliance and enforcement to address and prohibit the importation and sale of illicit flavored, disposable electronic nicotine delivery system (ENDS) products; Issues related to tobacco harm reduction efforts.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERILIFE GROUP, LLC via AKIN GUMP STRAUSS HAUER & FELD
2025 · third_quarter · Q3
Issues related to Medicare Advantage compensation, agent and broker policies.
Filing targets: HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE
AXON ENTERPRISE, INC. via AKIN GUMP STRAUSS HAUER & FELD
2025 · third_quarter · RR
Issues related to bipartisan legislation to address unintended regulatory impediment to procurement of next-gen tasers.
Issues related to bipartisan legislation to address unintended regulatory impediment to procurement of next-gen tasers.
BIOTECHNOLOGY INNOVATION ORGANIZATION via AKIN GUMP STRAUSS HAUER & FELD
2025 · second_quarter · Q2
Issues related to Rare Pediatric Disease Priority Review Voucher Program reauthorization; H.R. 1262/S. 932 - Give Kids a Chance Act of 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SOUTHEASTERN CONFERENCE via AKIN GUMP STRAUSS HAUER & FELD
2025 · second_quarter · Q2
Legislation regarding student athletes and college athletics.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HUMANE WORLD ACTION FUND (FKA HUMANE SOCIETY LEGISLATIVE FUND) via AKIN GUMP STRAUSS HAUER & FELD
2025 · second_quarter · Q2
Issues related to animal welfare, including H.R. 3732 - BARK Act, H.R. 3112/S. 1538 Better CARE for Animals Act of 2025, and Fiscal Year 2026 appropriations language regarding wild horses and burros; Issues related to S. 1326 - Food Security and Farm Protection Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR 21ST CENTURY PATENT REFORM via AKIN GUMP STRAUSS HAUER & FELD
2025 · second_quarter · Q2
Issues related to patent reform legislation; Issues related to H.R. 3152/S.1546 - Patent Eligibility Restoration Act of 2025; Issues related to H.R. 3160/S. 1553 - PREVAIL Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALTRIA CLIENT SERVICES LLC via AKIN GUMP STRAUSS HAUER & FELD
2025 · second_quarter · Q2
Issues related to compliance and enforcement to address and prohibit the importation and sale of illicit flavored, disposable electronic nicotine delivery system (ENDS) products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WILLIAMS & LAKE, LLC via AKIN GUMP STRAUSS HAUER & FELD
2025 · second_quarter · Q2
Issues related to pulsating brake light safety including H.R. 1361 - Collision Avoidance Systems Act of 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Transportation, Dept of (DOT)
AMERILIFE GROUP, LLC via AKIN GUMP STRAUSS HAUER & FELD
2025 · second_quarter · Q2
Issues related to Medicare Advantage compensation, agent and broker policies.
Filing targets: HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE
AMERICAN AIRLINES, INC via AKIN GUMP STRAUSS HAUER & FELD
2025 · second_quarter · Q2
Strategic and policy advice on issues related to the aviation industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SHATTERPROOF via AKIN GUMP STRAUSS HAUER & FELD
2025 · second_quarter · Q2
Issues related to Substance Use Disorder programs; H.R. 2483 - SUPPORT for Patients and Communities Reauthorization Act of 2025; Issues related to behavioral health; Promoting enhancements to the Substance Abuse and Mental Health Services Administration's mental health and addiction treatment locator, FindTreatment.gov, to include quality indicators for addiction treatment.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ENTERGY SERVICES, LLC via AKIN GUMP STRAUSS HAUER & FELD
2025 · second_quarter · Q2
Strategic and policy advice on utility-related issues.
Strategic and policy advice on utility-related issues.
Filing targets: HOUSE OF REPRESENTATIVES
BOOZ ALLEN HAMILTON INC. via AKIN GUMP STRAUSS HAUER & FELD
2025 · second_quarter · Q2
Issues related to Internal Revenue Service transformation.
Issues related to federal contracting.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE LEADERSHIP CONFERENCE ON CIVIL AND HUMAN RIGHTS via AKIN GUMP STRAUSS HAUER & FELD
2025 · second_quarter · Q2
Issues related to funding and accuracy of the 2030 Census.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SALESFORCE.COM, INC via AKIN GUMP STRAUSS HAUER & FELD
2025 · second_quarter · Q2
Issues related to artificial intelligence, privacy, and data security.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OPENAI OPCO, LLC via AKIN GUMP STRAUSS HAUER & FELD
2025 · second_quarter · Q2
Issues related to Artificial Intelligence legislation and regulation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL INDEPENDENT VENUE ASSOCIATION via AKIN GUMP STRAUSS HAUER & FELD
2025 · second_quarter · Q2
Issues related to predatory and deceptive practices in the ticketing market, including H.R. 1402/S. 281 - TICKET Act, and H.R. 2713/S. 196 - MAIN Event Ticketing Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MICROSOFT CORPORATION via AKIN GUMP STRAUSS HAUER & FELD
2025 · second_quarter · Q2
Issues related to technology and artificial intelligence.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMVCO, LLC via AKIN GUMP STRAUSS HAUER & FELD
2025 · second_quarter · Q2
Issues related to the role and responsibility of setting global payment standards to ensure interoperability and acceptance of secure payment transactions.
Issues related to the role and responsibility of setting global payment standards to ensure interoperability and acceptance of secure payment transactions.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AT&T SERVICES, INC. (FKA AT&T) via AKIN GUMP STRAUSS HAUER & FELD
2025 · second_quarter · Q2
Issues related to general telecommunications, broadband policy, and internet regulation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
1-800 CONTACTS via AKIN GUMP STRAUSS HAUER & FELD
2025 · second_quarter · Q2
Legislation related to the Federal Trade Commission Contact Lens Rule.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR 21ST CENTURY PATENT REFORM via AKIN GUMP STRAUSS HAUER & FELD
2025 · first_quarter · Q1
Issues related to patent reform legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SHATTERPROOF via AKIN GUMP STRAUSS HAUER & FELD
2025 · first_quarter · Q1
Issues related to Substance Use Disorder programs; SUPPORT Act reauthorization; Issues related to behavioral health; H.R. 7708/S. 3059 - REAL Health Providers Act (118th Congress).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VANTIVE US HEALTHCARE LLC via AKIN GUMP STRAUSS HAUER & FELD
2025 · first_quarter · Q1
Issues related to Medicare and provider reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES
KIPP FOUNDATION via AKIN GUMP STRAUSS HAUER & FELD
2025 · first_quarter · Q1
Issued related to federal funding for the Charter School Programs (CSP) and policies that support public charter education.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ENTERGY SERVICES, LLC via AKIN GUMP STRAUSS HAUER & FELD
2025 · first_quarter · Q1
Strategic and policy advice on utility-related issues.
Strategic and policy advice on utility-related issues.
Filing targets: HOUSE OF REPRESENTATIVES
EDUCATION REFORM NOW ADVOCACY via AKIN GUMP STRAUSS HAUER & FELD
2025 · first_quarter · Q1
Issues related to education reform.
Filing targets: HOUSE OF REPRESENTATIVES
SOCIETY OF MANUFACTURING ENGINEERS via AKIN GUMP STRAUSS HAUER & FELD
2025 · first_quarter · Q1
Issues related to manufacturing and workforce development.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BOOZ ALLEN HAMILTON INC. via AKIN GUMP STRAUSS HAUER & FELD
2025 · first_quarter · Q1
Issues related to electronic health record modernization.
Safety issues related to Federal Aviation Administration reauthorization.
Issues related to electronic health record modernization.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
STANLEY BLACK & DECKER, INC. via AKIN GUMP STRAUSS HAUER & FELD
2025 · first_quarter · Q1
Issues related to manufacturing generally; Issues related to workforce development and increased training; Issues related to advanced manufacturing education; General outreach on business activity; Issues related to tariffs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
BIOTECHNOLOGY INNOVATION ORGANIZATION via AKIN GUMP STRAUSS HAUER & FELD
2025 · first_quarter · Q1
Issues related to PAHPA reauthorization; Rare Pediatric Disease Priority Review Voucher Program reauthorization (H.R. 1262/S. 932 - Give Kids a Chance Act of 2025).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE LEADERSHIP CONFERENCE ON CIVIL AND HUMAN RIGHTS via AKIN GUMP STRAUSS HAUER & FELD
2025 · first_quarter · Q1
Issues related to funding and accuracy of the 2030 Census.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SALESFORCE.COM, INC via AKIN GUMP STRAUSS HAUER & FELD
2025 · first_quarter · Q1
Issues related to artificial intelligence, privacy, and data security.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE